Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany
Change in the Executive Board from September 1, 2025
Advertisement
Dr. Wolf-Henning Walther will take over as Managing Director of Metrohm Deutschland GmbH & Co. KG on September 1, 2025 and will form the Executive Board together with Michael Feige and Dr. Volker Frost. Frank Rückle, the current Managing Director, will take his well-deserved retirement on September 1, 2025.
After more than 40 successful years at Metrohm Germany, including almost 13 years on the Executive Board, Frank Rückle will be taking his well-deserved retirement on September 1, 2025. With his dedication, professional expertise and commitment to customers and employees, he has played a key role in shaping the company. We would like to thank him warmly for his many years of successful work and for the many impulses that Metrohm Germany has experienced during this time.
At the same time, Dr. Wolf-Henning Walther will become the new Managing Director of Metrohm Germany as of September 1. He not only brings with him extensive experience in the laboratory sector and fresh impetus, but also a long-standing personal connection to Metrohm. In his previous position, he worked on numerous exciting projects with some of his current colleagues. He not only got to know and appreciate the technical excellence, but also the values practiced at Metrohm.
"Even during my chemistry studies, I was very impressed by the uncompromising quality and robustness of the products - Made in Switzerland. I am now all the more looking forward to actively shaping the next chapters of this success story together with a great team," explains Dr. Wolf-Henning Walther, CEO, Managing Director at Metrohm Germany from September 1.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Opening the door to affordable lab-grown beef, cow cells defy aging - A potential game-changer for creating sustainable, ethical meat without the environmental toll of traditional livestock farming
Analytica USA celebrated its premiere on the US market - Key topics: digitalization and sustainability in the laboratory
"A DNA search engine" searches through millions of data records in seconds - This can significantly accelerate research into antibiotic resistance and unknown pathogens
Pancreatic cancer forms "synapses" - Pancreatic tumors use neurotransmitters to drive their own growth: Researchers hope to identify drugs that can block this process